medigraphic.com
ISSN 1561-3054 (Electronic)

2016, Number 1

<< Back Next >>

Rev Cubana Med Trop 2016; 68 (1)

Neurocryptococcosis in the context of HIV infection in Guayaquil, Ecuador

Sánchez GS, Zambrano CD, Martínez MGF, Fernández ACM, Illnait-Zaragozí MT

Language: Spanish
References: 25
Page: 20-29
PDF size: 138.07 Kb.


ABSTRACT

Introduction: neurocryptococcosis results from inhalation of yeasts from the Cryptococcus neoformans species complex. The disease mainly affects immunocompromised patients, causing high mortality rates.
Objective: describe infection due to Cryptococcus spp. in patients with HIV/AIDS from Guayaquil, Ecuador.
Methods: a descriptive cross-sectional prospective study was conducted from December 2013 to January 2015. Eighty-two cerebrospinal fluid samples were collected, as well as the demographic, clinical and laboratory data of an equal number of HIV seropositive inpatients from "Dr. José Daniel Rodríguez Maridueña" infectious diseases hospital. Cryptococcal infection was confirmed by India ink direct microscopic examination of cerebrospinal fluid, Sabouraud agar culture and conventional biochemical tests. The study met the ethical requirements established.
Results: 89.02% of the patients included in the study were male and 45.12% were in the 20-30 years age group. 33% had infection with C. neoformans, and their most common clinical features were diagnostic impression of neuroinfection (41%), headache (78%; 21/27), vomiting (85%; 23/27), weight loss (89%; 24/27); CD4 counts ‹ 200/uL (26%; 7/27), leucocytes 5 000-10 000 cells/mm3 (63%; 17/27), hemoglobin 11-15 g/dL (44%; 12/27) and hematocrit ‹ 35% (78%; 21/27). An association was also found between infection and the presence of vomiting, weight loss and adenopathies (prevalence ratio › 1).
Conclusions: cryptococcal infection is an important opportunistic mycosis in HIV/AIDS patients. It may be associated with certain features, which makes it possible to define control and prevention mechanisms.


REFERENCES

  1. Hagen F, Khayhan K, Theelen B, Kolecka A, Polacheck I, Sionoy E, et al. Recognition of seven species in the Cryptococcus gatti/Cryptococcus neoformans species complex, fungal genetics and biology. Fungal Gen Biol. 2015;78(5):16-48.

  2. Brizendine K, Pappas P. Cryptococcal meningitis: Current approaches to management in patients with and without AIDS. Curr Infect Dis Rep. 2010;12(4):229-305.

  3. Satishchandra P, Mathew T, Nagarathna S, Chandramukhi A, Mahadevan A. Cryptococcal meningitis: Clinical, diagnostic and therapeutic overviews. Neurol India. 2007;55(3):226-32.

  4. Hasimoto L, Rodriguez C, Lisboa O, Yano F, Silva T, Martins C, et al. Clinical and microbiological features of cryptococcal meningitis. Rev Soc Bras Med Trop. 2013;46(3):343-7.

  5. Illnait M, Martínez G, Fernández C, Hagen F, Boekhout T, Klaassen C, et al. Microsatellite typing and susceptibilities of serial Cryptococcus neoformans isolates from Cuban patients with recurrent cryptococcal meningitis. BMC Infect Dis. 2010;10(289):1-7.

  6. Kumar S, Wanchu A, Chakrabarti, Sharma A, Bambery P, Singh S. Cryptococcal meningitis in HIV infected: Experience from a north Indian tertiary center. Neurol India. 2008;56(4):444-9.

  7. Imwidthaya P, Poungvarin N. Cryptococcosis in AIDS. Postgrad Med J. 2000;76(892):85-8.

  8. Chiang H, Tettamanti D, Castro G. Tinta china en orina como método de diagnóstico en criptococosis diseminada asociado a VIH/sida. Estudio transversal realizado en el hospital de infectología "José Rodríguez M." durante el año 2009. Rev Med FCM-UCSG. 2010;16(2):16-23.

  9. Marquis G, Montplaisir S, Pelletice M, Mousseau S, Auger P. Genetic resistance to murine cryptococcosis increased susceptibility in the CBAINXID mutant strain of mice. Infect Immun. 1985;47:282-7.

  10. Cogliati M. Global molecular epidemiology of Cryptococcus neoformans and Cryptococcus gattii: An atlas of the molecular types. Scientifica. 2013;2013:1-23.

  11. Martín E, Aller A. Aspectos microbiológicos de las criptococosis en la era post- TARGA. Enferm Infecc Microbiol Clin. 2010;28(Supl 1):40-5.

  12. Mwaba P, Mwansa J, Chintu C, Pobee J, Scarborough M, Portsmouth S. Clinical presentation, natural history, and cumulative death rates of 230 adults with primary cryptococcal meningitis in Zambian AIDS patients treated under local conditions. Postgrad Med J. 2001;77(914):769-73.

  13. Bonifaz A. Criptococosis. México, D.F.: Méndez Cervantes; 2012.

  14. Perfect, Bicanic T. Cryptococcosis diagnosis and trearment: What we know now. Fungal Genet Biol. 2015;78(1):49-54.

  15. Lis A, Pan W, Wu S, Hideaki T, Guo N, Shen Y, et al. Ecological surveys of the Cryptococcus species complex in China. Chin Med J (Engl). 2012;125(3):511-6.

  16. Hubálek Z. Emerging Human Infectious Diseases: Anthroponoses, Zoonoses, and Sapronoses. Emerg Infect Dis. 2003;9(3):403-4.

  17. Bicanic T, Harrison T. Cryptococcal meningitis. Br Med Bull. 2005;72(1):99-118.

  18. Mwaba P, Mwansa J, Chintu C, Pobee J, Scarborough M, Portsmouth S. Clinical presentation, natural history, and cumulative death rates of 230 adults with primary cryptococcal meningitis in Zambian AIDS patients treated under local conditions. Postgrad Med J. 2001;77(914):769-73.

  19. Perfect J, Casadevall A. Cryotococcosis. Infect Dis Clin North Am. 2002;16(4):837-74.

  20. Baradkar V, Mathur M, Kumar S, Rathi M. Prevalence and clinical presentation of Cryptococcal meningitis among HIV seropositive patients. Indian J Sex Transm Dis & AIDS. 2009;30(1):19-22.

  21. Masalu MB. Etiologies, clinical characteristics and outcome of meningitis among HIV infected adults admitted to the medical wards of Bugando Medical Centre in Mwanza, Tanzania (Doctoral dissertarion, Catholic University of Health and Allied Sciences). 2013.

  22. Aslan S, Chandrasekhara P. Study of cryptococcal meningitis in HIV seropositive patients in a Tertiary Care Center. JIACM. 2009;10(3):110-5.

  23. Holikatti P, Kar N. Psychiatric manifestations in a patient with HIV-associated neurocognitive symptoms and cryptococcal meningitis. Indian J Psychol Med. 2012;4(4):381-2.

  24. Satishchandra P, Nalini A, Gourie-Devi M, Khanna N, Santos V, Ravi V, et al. Profile of neurological dosorders associated with HIV/AIDS from South India (1989-1996). Indian J Med Res. 2000;111:14-23.

  25. Xu X, Pan W, Bi X, Fang W, Chen M, Zhu Y, et al. Comparison of clinical features in patients with persistent and nonpersistent cryptococcal meningitis: twelve years of clinical experience in four centers in China. CNS Neurosci Ther. 2013;19(8):625-31.




2020     |     www.medigraphic.com